AI and gut bacteria may decide who can avoid surgery for rectal cancer

NCT ID NCT07566559

Recruiting now Knowledge-focused Sponsor: Beijing Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a smart model that uses scans, gut bacteria, and blood tests to see if rectal cancer patients can safely avoid surgery after initial treatment. Researchers will follow 869 patients to find out who can use a 'watch-and-wait' approach instead of an operation. The goal is to control the cancer while preserving the rectum and avoiding unnecessary surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help many rectal cancer patients avoid surgery and keep their organs, while still controlling the cancer.
What could go wrong: This is an observational study, not a treatment trial. The model may not be accurate enough to replace standard care, and results may take years to validate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal neoplasm rectum adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECTAL CANCER

Contacts and locations

Locations

Beijing Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, 100050, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.